Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines.

Source:http://linkedlifedata.com/resource/pubmed/id/10051630

Proc. Natl. Acad. Sci. U.S.A. 1999 Mar 2 96 5 2268-73

Download in:

View as

Triples

General Info

PMID
10051630